p-Cresyl sulfate promotes insulin resistance associated with CKD

Abstract : The mechanisms underlying the insulin resistance that frequently accompanies CKD are poorly understood, but the retention of renally excreted compounds may play a role. One such compound is p-cresyl sulfate (PCS), a protein-bound uremic toxin that originates from tyrosine metabolism by intestinal microbes. Here, we sought to determine whether PCS contributes to CKD-associated insulin resistance. Administering PCS to mice with normal kidney function for 4 weeks triggered insulin resistance, loss of fat mass, and ectopic redistribution of lipid in muscle and liver, mimicking features associated with CKD. Mice treated with PCS exhibited altered insulin signaling in skeletal muscle through ERK1/2 activation. In addition, exposing C2C12 myotubes to concentrations of PCS observed in CKD caused insulin resistance through direct activation of ERK1/2. Subtotal nephrectomy led to insulin resistance and dyslipidemia in mice, and treatment with the prebiotic arabino-xylo-oligosaccharide, which reduced serum PCS by decreasing intestinal production of p-cresol, prevented these metabolic derangements. Taken together, these data suggest that PCS contributes to insulin resistance and that targeting PCS may be a therapeutic strategy in CKD.
Type de document :
Article dans une revue
Journal of the American Society of Nephrology, American Society of Nephrology, 2013, 24 (1), pp.88-99. 〈10.1681/ASN.2012050503〉
Liste complète des métadonnées

https://hal.inria.fr/hal-00850482
Contributeur : Hedi Soula <>
Soumis le : mardi 6 août 2013 - 17:34:53
Dernière modification le : mardi 17 juillet 2018 - 15:49:24

Lien texte intégral

Identifiants

Citation

Laetitia Koppe, Nicolas J Pillon, Roxane E Vella, Marine L Croze, Caroline C Pelletier, et al.. p-Cresyl sulfate promotes insulin resistance associated with CKD. Journal of the American Society of Nephrology, American Society of Nephrology, 2013, 24 (1), pp.88-99. 〈10.1681/ASN.2012050503〉. 〈hal-00850482〉

Partager

Métriques

Consultations de la notice

543